Peter Tygesen | Business Development Director
SPI Pharma

Peter Tygesen, Business Development Director, SPI Pharma

Peter Tygesen brings more than 30 years of pharmaceutical industry experience and has spent over a decade focused on vaccine adjuvant innovation. He has played a significant role in supporting the development and commercialization of adjuvant technologies used globally.

Appearances:



Day 2 (21st October) @ 10:45

Innovative Adjuvants for Global Health

Session led by: SPI Pharma
last published: 25/Aug/26 09:55 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2026

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com


Stan Dooley

Stan.Dooley@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com